scholarly article | Q13442814 |
P356 | DOI | 10.1002/1097-0142(19811001)48:7<1569::AID-CNCR2820480717>3.0.CO;2-X |
P698 | PubMed publication ID | 6945143 |
P2093 | author name string | Bertoni F | |
Franceschi C | |||
Picci P | |||
Campanacci M | |||
Bacci G | |||
Minutillo A | |||
P2860 | cites work | Irradiation of the lungs as an adjuvant therapy in the treatment of osteosarcoma of the limbs. An E.O.R.T.C. randomized study | Q41403761 |
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1569-1581 | |
P577 | publication date | 1981-10-01 | |
P1433 | published in | Cancer | Q326041 |
P1476 | title | The treatment of osteosarcoma of the extremities: twenty year's experience at the Istituto Ortopedico Rizzoli | |
P478 | volume | 48 |
Q66812375 | A humeral modular prostheses for bone tumour surgery: a study of 56 cases |
Q40179159 | A novel small molecule Met inhibitor, PF2362376, exhibits biological activity against osteosarcoma. |
Q56996677 | Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients |
Q94322242 | Chemotherapy for treating high‐grade osteosarcoma in children and young adults |
Q47360357 | Current and future therapeutic approaches for osteosarcoma. |
Q37265109 | Current status and perspectives regarding the treatment of osteo-sarcoma: chemotherapy |
Q38161735 | Current therapeutic strategies and novel approaches in osteosarcoma |
Q34307165 | Current treatment of high grade osteosarcoma of the extremity: review |
Q50856812 | Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma. |
Q27307103 | Expression of the chemokine receptor CXCR7 in CXCR4-expressing human 143B osteosarcoma cells enhances lung metastasis of intratibial xenografts in SCID mice |
Q50861517 | Heat shock protein 72 expression in osteosarcomas correlates with good response to neoadjuvant chemotherapy. |
Q38219831 | Historical perspective on the introduction and use of chemotherapy for the treatment of osteosarcoma |
Q40830532 | Historical, current and future aspects of osteosarcoma treatment |
Q37782098 | How can survival be improved in localized osteosarcoma? |
Q33557868 | Inhibition of tumors cell growth in osteosarcoma-bearing SD rats through a combination of conventional and metronomic scheduling of neoadjuvant chemotherapy |
Q70906953 | Intracortical osteosarcoma: rare entity or early manifestation of classical osteosarcoma? |
Q67923500 | Isolation perfusion of the lower limb with platinum |
Q78029619 | Letter to the editor: osteogenic sarcoma--cutaneous metastases |
Q41613919 | Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy. |
Q34588488 | Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution |
Q72027269 | Magnetic resonance relaxation times of normal tissue in the course of chemotherapy: a study in patients with bone sarcoma |
Q44459385 | Malignant fibrous histiocytoma of bone the experience at the Rizzoli Institute: Report of 90 cases |
Q74751280 | Malignant tumors of the osteogenic matrix |
Q37941806 | Management of canine appendicular osteosarcoma |
Q73837751 | Massive bone allografts in the treatment of pathologic fractures due to bone metastases |
Q30881881 | National Cancer Data Base report on osteosarcoma of the head and neck. |
Q32100844 | Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol |
Q36490672 | Nuclear polymorphism in osteosarcomas as a prognostic factor for the effect of chemotherapy. A quantitative study |
Q41704948 | On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy |
Q36743183 | Osteosarcoma: then and now. A fifty year review at Royal Prince Alfred Hospital |
Q40169054 | Pain in the Cancer Patient as a Consequence of Therapy (Surgery, Radiotherapy, Chemotherapy) |
Q57008525 | Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy |
Q43754201 | Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute |
Q35921352 | Present-day concepts in the management of sarcomas in children |
Q36803705 | Prevalence of Metastasis at Diagnosis of Osteosarcoma: An International Comparison |
Q34135065 | Proteins expressed in osteosarcoma and serum levels as prognostic factors |
Q36731426 | Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies. |
Q73702556 | Serum antibodies against the heat shock protein 60 are elevated in patients with osteosarcoma |
Q67726432 | Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experience |
Q38232992 | Systematic review of high-dose and standard-dose chemotherapies in the treatment of primary well-differentiated osteosarcoma |
Q33279107 | Telomerase activity in skeletal sarcomas |
Q35858388 | The efficacy of high-dose versus moderate-dose chemotherapy in treating osteosarcoma: a systematic review and meta-analysis |
Q70929821 | The pathologist's role in the diagnosis and treatment of osteosarcoma in children |
Q37409192 | Therapeutic efficacy of soluble receptor activator of nuclear factor-kappa B-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma |
Q40387200 | Treatment recommendations for osteosarcoma and adult soft tissue sarcomas |
Q38520992 | Trends and variability in survival among patients with osteosarcoma: a 7-year update |
Q57000995 | Twenty-year follow-up of osteosarcoma of the extremity treated with adjuvant chemotherapy |
Q34161337 | What are the factors that affect survival and relapse after local recurrence of osteosarcoma? |
Q69817164 | [New morphologic findings in malignant bone tumors] |
Search more.